(Q36067727)

12 August 2017

1 reference

title

Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study (English)

1 reference

idiopathic pulmonary fibrosis

12 August 2017

1 reference

1 reference

Kristin B Highland

1

1 reference

PubMed ID

15760593

12 August 2017

Richard M Silver

series ordinal

2

1 reference

12 August 2017

1 April 2005

1 reference

Current Rheumatology Reports

12 August 2017

1 reference

12 August 2017

7

1 reference

12 August 2017

2

1 reference

12 August 2017

135-141

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-005-0066-z

12 August 2017

0 references

cites work

Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern.

1 reference

https://api.crossref.org/works/10.1007%2FS11926-005-0066-Z

Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-005-0066-Z

Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-005-0066-Z

Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-005-0066-Z

The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-005-0066-Z

Interstitial lung disease in systemic sclerosis

21 January 2018

1 reference

12 December 2020

Interstitial lung disease and gastroesophageal reflux.

1 reference

12 December 2020

Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test results

1 reference

12 December 2020

Pulmonary scleroderma

1 reference

12 December 2020

Esophageal involvement and pulmonary manifestations in systemic sclerosis

1 reference

12 December 2020

Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis

1 reference

12 December 2020

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

1 reference

12 December 2020

Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis

1 reference

12 December 2020

BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia.

1 reference

12 December 2020

Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis

1 reference

12 December 2020

Increased surfactant protein-A levels in patients with newly diagnosed idiopathic pulmonary fibrosis

1 reference

12 December 2020

Elevated serum KL-6 levels in patients with systemic sclerosis: association with the severity of pulmonary fibrosis.

1 reference

12 December 2020

High resolution computed tomography in early scleroderma lung disease

1 reference

12 December 2020

Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.

1 reference

12 December 2020

Pulmonary function in patients with systemic sclerosis

1 reference

12 December 2020

Increased nitric oxide in exhaled air in patients with systemic sclerosis

1 reference

12 December 2020

Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study

1 reference

12 December 2020

Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma

1 reference

12 December 2020

Relationship between cutaneous and pulmonary involvement in systemic sclerosis

1 reference

12 December 2020

Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia

1 reference

12 December 2020

Isolated diffusing capacity reduction in systemic sclerosis

1 reference

12 December 2020

Exhaled nitric oxide is elevated in patients with progressive systemic sclerosis without interstitial lung disease

1 reference

12 December 2020

Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis?

1 reference

12 December 2020

The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia.

1 reference

12 December 2020

Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis

1 reference

12 December 2020

B-Cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis

1 reference

12 December 2020

Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis

1 reference

12 December 2020

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

1 reference

12 December 2020

Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study

1 reference

12 December 2020

Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis

1 reference

12 December 2020

Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

1 reference

12 December 2020

A longitudinal study of pulmonary function in Danish patients with systemic sclerosis.

1 reference

12 December 2020

Scleroderma. Clinical problems. The lungs

1 reference

12 December 2020

Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.

1 reference

12 December 2020

Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement

1 reference

12 December 2020

Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis.

1 reference

12 December 2020

Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis.

1 reference

12 December 2020

Scleroderma patients with combined pulmonary hypertension and interstitial lung disease.

1 reference

12 December 2020

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

1 reference

12 December 2020

Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis

1 reference

12 December 2020

Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT

1 reference

12 December 2020

Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis

1 reference

12 December 2020

Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage

1 reference

12 December 2020

Pulmonary function in scleroderma

1 reference

12 December 2020

Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung

1 reference

12 December 2020

Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT

1 reference

12 December 2020

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

1 reference

12 December 2020

Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis

1 reference

12 December 2020

Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis.

1 reference

12 December 2020

Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis.

1 reference

12 December 2020

Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis

1 reference

12 December 2020

Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis

1 reference

12 December 2020

Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

1 reference

12 December 2020

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease

1 reference

12 December 2020

Severe organ involvement in systemic sclerosis with diffuse scleroderma

1 reference

12 December 2020

CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.

1 reference

12 December 2020

Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension

1 reference

12 December 2020

Histopathologic variability in usual and nonspecific interstitial pneumonias

1 reference

12 December 2020

Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26 patients

1 reference

12 December 2020

Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage

1 reference

12 December 2020

Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.

1 reference

12 December 2020

10.1007/S11926-005-0066-Z

Identifiers

DOI

1 reference

release_daeuqmrk5zfmfdumpxx2hjqgmy

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/daeuqmrk5zfmfdumpxx2hjqgmy

24 November 2022

mapped directly with Wikidata item

PubMed ID

15760593

1 reference

PubMed ID

15760593